Oxybutynin CL ER 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FKYBF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,806
Award facts
- Contract value 100% obligated
- $5,805.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,805.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Oxybutynin Chloride Extended Release 10 mg tablets in a 90-day supply quantity. The contract, which was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation and represents a discrete delivery order under DMS Pharmaceutical Group's larger indefinite delivery contract with the agency. The place of performance is Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's substantial $499.999 billion indefinite delivery contract with the Defense Logistics Agency under the SPE2DB program, valid through November 2026. The parent contract enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide, encompassing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent capability in fulfilling diverse pharmaceutical requirements for Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FKYBF?
SPE2DB25FKYBF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FKYBF worth?
The government has obligated $5,806 on SPE2DB25FKYBF.
Is contract SPE2DB25FKYBF an order under another contract?
Yes. SPE2DB25FKYBF is a delivery order under SPE2DB24D9801, an indefinite delivery contract.
Was contract SPE2DB25FKYBF competed?
The extent of competition for SPE2DB25FKYBF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award